Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Based in Indianapolis, IN, and formed through the merger of Anthem Inc. and WellPoint Health Networks Inc. in Nov 2004, Anthem Inc. is one of the largest publicly traded managed care organizations in terms of membership. The company was previously named WellPoint Inc. (WLP). The company is also an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Anthem is the largest BCBS plan provider in the United States. As of Mar 31, 2020, it catered to 42.1 million medical members through its affiliated health plans.
Why Retaining Cigna (CI) Stock for Now is a Prudent Move?
by Zacks Equity Research
Cigna (CI) expects growth of at least 350,000 customers in 2021 to ramp up total medical clients.
Centene (CNC) Up 4.8% on Upbeat '22 Guidance: Key Details
by Zacks Equity Research
Centene (CNC) expects bottom-line growth to be supported by lower expenses and gross margin improvement.
UnitedHealth's (UNH) Arms Receive Rating Actions From AM Best
by Zacks Equity Research
UnitedHealth's (UNH) subsidiaries get rating upgrades from AM Best. Moreover, outlook of the ratings is revised to stable.
Top Stock Reports for Microsoft, NVIDIA & Medtronic
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), NVIDIA Corporation (NVDA), and Medtronic plc (MDT).
UnitedHealth (UNH) Ups Guidance: Here's What You Should Know
by Zacks Equity Research
UnitedHealth's (UNH) 2022 bottom line estimates are below the Zacks Consensus Estimate, may be due to an uptick in insurance claims triggered by the coronavirus pandemic.
Anthem (ANTM) Down 1.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Anthem (ANTM) to Acquire Integra to Enhance Medicaid Business
by Zacks Equity Research
Anthem (ANTM) to buy Integra Managed Care from a wholly-owned indirect unit of Personal Touch Holding Corporation to bolster its Medicaid Business profile.
Cigna (CI) to Post Earnings in Q3: What's in the Offing?
by Zacks Equity Research
Cigna's (CI) Q3 results are likely to reflect growth in earnings and revenues.
Acadia Healthcare (ACHC) Q3 Earnings Meet Estimates, Rise Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q3 results reflect higher revenues, driven by solid demand for its behavioral health services and higher admissions.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
Encompass Health (EHC) Misses on Q3 Earnings, Cuts '21 EPS View
by Zacks Equity Research
Encompass Health's (EHC) third-quarter earnings miss estimates but improve year over year on the back of top-line growth resulting from a sound Inpatient Rehabilitation segment.
Universal Health (UHS) Q3 Earnings Miss Mark, Decline Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results reflect high expenses, partly offset by better revenues.
Centene's (CNC) Q3 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Centene's (CNC) third-quarter results reflect improved revenues, better Medicare and Medicaid membership growth, partly offset by higher SG&A costs.
Breast Health Sales to Drive Hologic's (HOLX) Q4 Earnings
by Zacks Equity Research
The acquisition of Biotheranostics and the launch of new software are expected to have contributed to Hologic's (HOLX) Breast Health arm performance in the fourth quarter.
4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes
by Srijita Guha
Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.
Hologic (HOLX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Hologic's (HOLX) recent acquisitions and product launches are expected to contribute significantly to its fourth-quarter performance.
HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 earnings results reflect gains from patient volumes and better revenues.
Tenet Healthcare (THC) Q3 Earnings Beat Mark, Increase Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings results reflect better revenues and higher patient volumes.
Stock Market News for Oct 21, 2021
by Zacks Equity Research
The Dow and the S&P 500 ended near an all-time high on Wednesday, lifted by the Federal Reserve's latest Beige Book report that points to a modest growth pace of the US economy, and upbeat third-quarter earnings report.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Anthem's (ANTM) third-quarter results reflect higher revenues and solid contribution from its segments.
Anthem (ANTM) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Anthem (ANTM) delivered earnings and revenue surprises of 6.93% and 0.60%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Anthem (ANTM) This Earnings Season?
by Zacks Equity Research
Anthem (ANTM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Hologic (HOLX) to Expand Surgical Portfolio With Bolder Buyout
by Zacks Equity Research
Hologic's (HOLX) recent acquisition will accelerate its growth and enhance patient outcomes by leveraging significant commercial resources and strong relationships with OB/GYN specialists.
Why Anthem (ANTM) Could Beat Earnings Estimates Again
by Zacks Equity Research
Anthem (ANTM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.